EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...

It is noteworthy that patients with mild TBI often report visual issues despite normal results of visual acuity measurements ...

More than 300 patients have been randomized in the SOL-1 Phase 3 trial for OTX-TKI (AXPAXLI, axitinib intravitreal implant).

Researchers described the presence of multiple bilateral serous retinal detachments (SRDs) found in 3 women after they used ...

The authors searched PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports ...

To educate the public—including parents, caregivers, and allied health professionals—Prevent Blindness is offering free educational resources, including fact sheets, social media graphics, web pages, ...

Samsung Bioepis has named Kyung-Ah Kim President and Chief Executive Officer of the company. Kim will succeed Christopher Hansung Ko, who has been appointed to lead Samsung Future Business Division. 1 ...

Outlook Therapeutics revealed preliminary topline results of NORSE EIGHT, the second of 2 adequate and well controlled clinical trials evaluating ONS-5010 in wet AMD patients. In the NORSE EIGHT trial ...

An international study conducted by researchers in Indonesia, The Netherlands, the UK, and Singapore reported that about one-third of patients with ocular tuberculosis (OTB) in a low tuberculosis (TB) ...